Invesco Ltd. Ocular Therapeutix, Inc Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Invesco Ltd. holds 1,538,846 shares of OCUL stock, worth $19.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,538,846

Previous 804,829 91.2%

Holding current value

$19.2 Million

Previous $5.9 Million 142.07%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.02 - $9.46 $4.42 Million - $6.94 Million	734,017 Added 91.2%	1,538,846 $14.3 Million
Q1 2025 May 12, 2025	SELL	$5.93 - $9.08 $505,336 - $773,770	-85,217 Reduced 9.57%	804,829 $5.9 Million
Q4 2024 Feb 13, 2025	BUY	$8.33 - $11.47 $1.12 Million - $1.54 Million	134,573 Added 17.81%	890,046 $7.6 Million
Q3 2024 Nov 12, 2024	BUY	$6.45 - $9.23 $4.58 Million - $6.55 Million	709,573 Added 1545.91%	755,473 $6.57 Million
Q2 2024 Aug 13, 2024	SELL	$4.2 - $8.69 $3.05 Million - $6.31 Million	-726,466 Reduced 94.06%	45,900 $313,000
Q1 2024 May 14, 2024	BUY	$3.85 - $10.93 $2.12 Million - $6.03 Million	551,339 Added 249.44%	772,366 $7.03 Million
Q4 2023 Feb 12, 2024	SELL	$2.08 - $4.52 $60,136 - $130,682	-28,912 Reduced 11.57%	221,027 $985,000
Q3 2023 Nov 13, 2023	BUY	$3.14 - $5.04 $224,164 - $359,805	71,390 Added 39.98%	249,939 $784,000
Q2 2023 Aug 11, 2023	BUY	$4.6 - $7.64 $43,226 - $71,793	9,397 Added 5.56%	178,549 $921,000
Q1 2023 May 12, 2023	SELL	$2.79 - $6.27 $269,572 - $605,813	-96,621 Reduced 36.35%	169,152 $891,000
Q4 2022 Feb 13, 2023	BUY	$2.61 - $4.41 $338,746 - $572,365	129,788 Added 95.44%	265,773 $746,000
Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $151,158 - $240,227	-36,958 Reduced 21.37%	135,985 $564,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $37,983 - $65,871	12,619 Added 7.87%	172,943 $695,000
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $112,176 - $170,703	23,225 Added 16.94%	160,324 $794,000
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $188,853 - $370,042	30,658 Added 28.8%	137,099 $955,000
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $173,853 - $257,015	17,923 Added 20.25%	106,441 $1.06 Million
Q2 2021 Aug 17, 2021	BUY	$13.43 - $19.16 $351,140 - $500,957	26,146 Added 41.92%	88,518 $1.26 Million
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $14.8 Million - $20.8 Million	-938,524 Reduced 93.77%	62,372 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $6.42 Million - $18.6 Million	811,055 Added 427.23%	1,000,896 $20.7 Million
Q3 2020 Nov 16, 2020	SELL	$7.36 - $9.87 $3.04 Million - $4.07 Million	-412,832 Reduced 68.5%	189,841 $1.45 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $2.17 Million - $4.15 Million	463,694 Added 333.64%	602,673 $5.02 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $548,967 - $1.03 Million	138,979 New	138,979 $688,000
Q2 2019 Aug 14, 2019	SELL	$2.46 - $4.52 $703,850 - $1.29 Million	-286,118 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.51 - $4.77 $240,329 - $326,601	68,470 Added 31.46%	286,118 $1.14 Million
Q4 2018 Feb 14, 2019	BUY	$3.87 - $7.11 $842,297 - $1.55 Million	217,648 New	217,648 $866,000

Others Institutions Holding OCUL

# of Institutions

203

Shares Held

137M

Call Options Held

743K

Put Options Held

321K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $961M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account